| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $27.7M | +14.1% |
| SG&A Expense | $14.1M | +14.8% |
| Operating Income | -$41.8M | -14.3% |
| Pre-tax Income | -$36.9M | -4.5% |
| Income Tax | $0 | — |
| Net Income | -$36.9M | -4.5% |
| EPS (Basic) | -$0.84 | +38.7% |
| EPS (Diluted) | -$0.84 | +38.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.7M | -0.3% |
| Current Assets | $90.2M | -25.3% |
| Total Assets | $95.9M | -24.1% |
| Current Liabilities | $9.5M | -11.2% |
| Total Liabilities | $14.2M | -8.3% |
| Stockholders' Equity | $81.7M | -26.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.5M | -21.4% |
| Capital Expenditures | $164K | +64.0% |
| Investing Cash Flow | $33.4M | +136.7% |
| Financing Cash Flow | $30K | -100.0% |
| Free Cash Flow | -$33.6M | -21.5% |